![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/29/2871063/0/en/George-Medicines-Appoints-Mark-Mallon-as-Chief-Executive-Officer-and-Board-Director.html
https://www.globenewswire.com/news-release/2023/07/12/2703376/0/en/George-Medicines-completes-recruitment-of-first-Phase-III-hypertension-trial-investigating-novel-single-pill-triple-combination-candidate-GMRx2.html
https://pharmaphorum.com/news/george-taps-medisante-tech-for-decentralised-blood-pressure-trial/
https://www.globenewswire.com/news-release/2022/09/07/2511098/0/en/George-Medicines-provides-single-pill-triple-combination-candidate-for-hypertension-to-VERONICA-Nigeria-trial.html
https://www.globenewswire.com/news-release/2022/07/20/2482539/0/en/George-Medicines-advances-triple-combination-candidate-GMRx4-into-Phase-II-clinical-development-for-first-line-treatment-of-type-2-diabetes.html
https://www.globenewswire.com/news-release/2022/01/17/2367541/0/en/Clinical-trial-begins-in-the-UK-to-investigate-3-in-1-high-blood-pressure-pill.html